Sort by
Refine Your Search
-
approaches developed in the lab, and develop novel cancer immunotherapies targeting metastatic cancer cells. Cancer immunotherapy is one of the most important breakthroughs in the development of cancer
-
aging and age-associated metabolic disorders. Ultimately, the lab’s aim is to mitigate pathogenesis and develop effective treatments for chronic metabolic diseases. The lab has developed unique and
-
staff and is responsible for the development and execution of major research projects and performs state-of-the-art, complex research projects in collaboration with the other researchers, making
-
About the lab We are a newly established computational research group at the Translational Genomics Research Institute developing and applying pangenome methods to study genome variation and
-
, Cancer Biology, Chromatin Regulation, Cancer Epigenetics, Epigenetics Regulation, Cancer Metabolism, Immunology, Drug Discovery, Development, and Structural Biology, with an emphasis on RNA epigenetics
-
successful candidate, you will: This project with Dr. Nagarajan Vaidehi involves developing and application of interpretable machine learning methods to uncover allosteric regulation of disordered regions in
-
to vaccine development utilizing viral vectors to contribute to an effort in developing neoantigen expressing vaccines for clinical investigations. The position is available as part of a multi-disciplinary
-
treatment planning, treatment delivery and assessment of treatment outcomes. As a successful candidate, you will: Develop MR pulse sequences and perform image reconstruction. Conduct medical imaging post
-
tools to identify novel signaling pathways to develop new targets for drug discovery. Our research interests include: 1) Liver-gut and microbiota crosstalk as metabolic mediators in regulating both normal
-
. This project involves the development and application of interpretable machine learning methods to uncover allosteric regulation of disordered regions in the dynamics of G-protein coupled receptors to enable